Boston Scientific acquires RFA manufacturer Cosman Medical

Boston Scientific (NYSE:BSX) said today it picked up Burlington, Mass.-based radiofrequency ablation system manufacturer Cosman Medical for an undisclosed amount.

Through the acquisition, Cosman Medical’s team and products will be folded into Boston Scientific’s neuromodulation business, the company said.

“This acquisition is a natural extension of our current product portfolio and will help us provide physicians and patients more options to address chronic pain with non-opioid therapeutic treatments. The addition of the Cosman Medical product line, which is built on industry-leading technology and known for its high-quality, expands our capability to provide innovative solutions for the treatment of chronic pain,” Boston Scientific neuromodulation prez Maulik Nanavaty said in a press release.

Marlborough, Mass.-based Boston Scientific said it expects the net impact of the acquisition on adjusted earnings per share to break-even this year and be accretive moving forward.

“We are pleased to join the Boston Scientific team and help expand access to leading treatments for chronic pain. This acquisition comes at a time when our society is recognizing the impact of relying extensively on opioids to treat pain and is looking for additional approaches. Our mutual commitment to innovation and quality will help us deliver solutions,” Cosman Medical scientific director Eric Cosman Jr said in prepared remarks.

Earlier this month, Boston Scientific reportedly opened a new research & development facility in Gurgaon, India, which is its largest R&D shop outside the U.S.

The 100,000-square-foot center, called the Institute for Advancing Science, also includes training and commercial facilities, according to the Business Standard.

Boston Scientific said in June that the next stage in the turnaround engineered by chairman & CEO Mike Mahoney will involve an unspecified number of layoffs, although its overall headcount will likely remain “relatively unchanged.” The reorganization aims to cut pre-tax expenses by $115 million to $150 million by the end of 2020.

The post Boston Scientific acquires RFA manufacturer Cosman Medical appeared first on MassDevice.

from MassDevice http://ift.tt/2adSBX7